NASDAQ:ANGO AngioDynamics (ANGO) Stock Price, News & Analysis $11.78 -0.09 (-0.76%) Closing price 04:00 PM EasternExtended Trading$11.78 0.00 (0.00%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About AngioDynamics Stock (NASDAQ:ANGO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get AngioDynamics alerts:Sign Up Key Stats Today's Range$11.62▼$12.0150-Day Range$10.90▼$15.6852-Week Range$9.39▼$16.29Volume298,556 shsAverage Volume641,074 shsMarket Capitalization$495.35 millionP/E RatioN/ADividend YieldN/APrice Target$19.00Consensus RatingModerate Buy Company Overview AngioDynamics, Inc. develops, manufactures and markets medical devices used in minimally invasive procedures. Its products are designed for clinicians in areas including vascular access, peripheral vascular disease and oncology. The company’s offerings include vascular access devices such as ports and catheters, as well as technologies used in vascular intervention and cancer treatment. These include the Auryon atherectomy system, which is used to treat certain peripheral arterial conditions, and the NanoKnife System, which uses irreversible electroporation in tumor ablation procedures. AngioDynamics sells its products in the United States and internationally. The company is headquartered in Latham, New York.AI Generated. May Contain Errors. Read More AngioDynamics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks60th Percentile Overall ScoreANGO MarketRank™: 3.02066772655 of 5 starsAngioDynamics scored higher than 60% of companies evaluated by MarketBeat, and ranked 366th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.1 / 5Analyst RatingModerate Buy Consensus RatingAngioDynamics has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 1 strong buy rating, 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialAngioDynamics has a consensus price target of $19.00, representing about 61.3% upside from its current price of $11.78.Amount of Analyst CoverageAngioDynamics has only been the subject of 4 research reports in the past 90 days.Read more about AngioDynamics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for AngioDynamics are expected to grow in the coming year, from ($0.27) to ($0.16) per share.Price to Book Value per Share RatioAngioDynamics has a P/B Ratio of 2.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about AngioDynamics' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted5.07% of the float of AngioDynamics has been sold short.Short Interest Ratio / Days to CoverAngioDynamics has a short interest ratio ("days to cover") of 2.92, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AngioDynamics has recently increased by 4.52%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAngioDynamics does not currently pay a dividend.Dividend GrowthAngioDynamics does not have a long track record of dividend growth. News and Social Media2.5 / 5News Sentiment0.97 News SentimentAngioDynamics has a news sentiment score of 0.97. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for AngioDynamics this week, compared to 4 articles on an average week. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, AngioDynamics insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $310,688.00 in company stock.Percentage Held by Insiders6.00% of the stock of AngioDynamics is held by insiders.Percentage Held by Institutions89.43% of the stock of AngioDynamics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about AngioDynamics' insider trading history. Receive ANGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AngioDynamics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ANGO Stock News HeadlinesAngioDynamics, Inc. (NASDAQ:ANGO) Stock Now Rated "Moderate Buy" by Wall Street AnalystsNovember 14 at 3:50 AM | americanbankingnews.comHead to Head Comparison: Koninklijke Philips (NYSE:PHG) versus AngioDynamics (NASDAQ:ANGO)November 7, 2026 | americanbankingnews.comYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.November 16 at 1:00 AM | Paradigm Press (Ad)AngioDynamics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)November 6, 2026 | businesswire.comAngioDynamics (NASDAQ:ANGO) CFO Sells 1,720 Shares of Company StockOctober 31, 2026 | insidertrades.comAngioDynamics Announces Publication of DIRECT Study Results and New Category I CPT Code for Pancreatic IREOctober 21, 2026 | finance.yahoo.comAngioDynamics: Progress Evident, But Volatility And Margin Concerns PersistOctober 15, 2026 | seekingalpha.comAngioDynamics Shares Fall 4.3% Despite Q1 Earnings Beat and Strong Med Tech GrowthOctober 9, 2026 | finance.yahoo.comSee More Headlines ANGO Stock Analysis - Frequently Asked Questions How have ANGO shares performed this year? AngioDynamics' stock was trading at $12.84 at the beginning of 2026. Since then, ANGO stock has decreased by 8.3% and is now trading at $11.78. How were AngioDynamics' earnings last quarter? AngioDynamics, Inc. (NASDAQ:ANGO) released its quarterly earnings results on Thursday, October, 8th. The medical instruments supplier reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.07. The medical instruments supplier had revenue of $80.92 million for the quarter, compared to the consensus estimate of $80.51 million. AngioDynamics had a negative trailing twelve-month return on equity of 4.49% and a negative net margin of 10.12%. Read the conference call transcript. Does AngioDynamics have any subsidiaries? The following companies are subsidiaries of AngioDynamics: Eximo Medical Ltd., RadiaDyne LLC, Clinical Devices, Vortex Medical, Navilyst Medical Inc., FlowMedica, Oncovionic, and more. Who are AngioDynamics' major shareholders? Top institutional shareholders of AngioDynamics include Royce & Associates LP (4.57%), Weber Capital Management LLC ADV (3.21%), State Street Corp (2.35%) and Marshall Wace LLP (1.44%). Insiders that own company stock include James C Clemmer, James C Clemmer, Stephen A Trowbridge, Lawrence T Weiss and Warren Nighan Jr. View institutional ownership trends. How do I buy shares of AngioDynamics? Shares of ANGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AngioDynamics own? Based on aggregate information from My MarketBeat watchlists, some other companies that AngioDynamics investors own include NVIDIA (NVDA), Micron Technology (MU), Salesforce (CRM), Verizon Communications (VZ), Intel (INTC), Advanced Micro Devices (AMD) and PayPal (PYPL). Company Calendar Last Earnings10/08/2026Today11/16/2026AGM 202611/17/2026Next Earnings (Estimated)1/06/2027Fiscal Year End5/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ANGO's financial health is in the Yellow zone, according to TradeSmith. ANGO has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ANGO CIK1275187 Webwww.angiodynamics.com Phone(518) 795-1400Fax518-795-1401Employees632Year Founded1988Price Target and Rating Average Price Target for AngioDynamics$19.00 High Price Target$20.00 Low Price Target$18.00 Potential Upside/Downside+61.3%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$36.74 million Net Margins-10.12% Pretax Margin-10.07% Return on Equity-4.49% Return on Assets-2.96% Debt Debt-to-Equity RatioN/A Current Ratio2.40 Quick Ratio1.48 Sales & Book Value Annual Sales$320.17 million Price / Sales1.55 Cash Flow$0.31 per share Price / Cash Flow38.31 Book Value$4.13 per share Price / Book2.85Miscellaneous Outstanding Shares42,050,000Free Float39,531,000Market Cap$495.35 million OptionableOptionable Beta0.30 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:ANGO) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman and Jensen Huang could one day be worth more than Ap...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.